240 related articles for article (PubMed ID: 24519899)
1. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
4. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
5. Gene-environment interactions in determining differences in genetic susceptibility to cancer in subsites of the head and neck.
Maurya SS; Katiyar T; Dhawan A; Singh S; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2015 Apr; 56(3):313-21. PubMed ID: 25399842
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
[TBL] [Abstract][Full Text] [Related]
7. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
[TBL] [Abstract][Full Text] [Related]
9. Association of functionally important polymorphisms in cytochrome P450s with squamous cell carcinoma of head and neck.
Ruwali M; Parmar D
Indian J Exp Biol; 2010 Jul; 48(7):651-65. PubMed ID: 20929050
[TBL] [Abstract][Full Text] [Related]
10. Interaction of cytochrome P450s with environmental risk factors increases their expression and risk to head and neck cancer.
Katiyar T; Yadav V; Maurya SS; Hasan F; Singh AP; Yadav S; Singh S; Hadi R; Bhatt MLB; Parmar D
Environ Mol Mutagen; 2022 Jun; 63(5):255-264. PubMed ID: 35638572
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer.
Ruwali M; Singh M; Pant MC; Parmar D
Xenobiotica; 2011 Dec; 41(12):1122-30. PubMed ID: 21957883
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
17. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
Yadav SS; Ruwali M; Shah PP; Mathur N; Singh RL; Pant MC; Parmar D
Mutat Res; 2008 Sep; 644(1-2):31-7. PubMed ID: 18644391
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
[TBL] [Abstract][Full Text] [Related]
19. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
Olshan AF; Weissler MC; Watson MA; Bell DA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
Harth V; Schafer M; Abel J; Maintz L; Neuhaus T; Besuden M; Primke R; Wilkesmann A; Thier R; Vetter H; Ko YD; Bruning T; Bolt HM; Ickstadt K
J Toxicol Environ Health A; 2008; 71(13-14):887-97. PubMed ID: 18569591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
